Sanofi-Aventis Recherche & Developpement

Immune-Mediated Inflammatory Diseases

Clinical research includes ulcerative colitis, Crohn’s disease, rheumatoid arthritis, systemic lupus erythematosus, and systemic juvenile idiopathic arthritis, with additional interest in coeliac disease and chronic graft versus host disease.

  • Ulcerative colitis
  • Crohn’s disease
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Chronic graft versus host disease

Research also extends to immune thrombocytopenia, autoimmune haemolytic anaemia, and other immune system diseases.

Dermatology and Allergic Disease

Studies cover atopic dermatitis, psoriasis, hidradenitis suppurativa, pruritus, and chronic rhinosinusitis with nasal polyps, alongside asthma and other respiratory tract diseases.

  • Atopic dermatitis
  • Psoriasis
  • Hidradenitis suppurativa
  • Asthma
  • Chronic rhinosinusitis with nasal polyps

Additional activity includes chronic obstructive pulmonary disease and bronchiectasis within broader respiratory disease research.

Haematology, Oncology, and Plasma Cell Disorders

Research spans multiple myeloma, plasma cell myeloma, relapsed/refractory multiple myeloma, acute myeloid leukemia, acute lymphocytic leukaemia, and myelodysplastic syndrome.

  • Multiple myeloma
  • Acute myeloid leukemia
  • Acute lymphocytic leukaemia
  • Myelodysplastic syndrome
  • Non-small cell lung cancer

Other areas include solid tumours, plasma cell myeloma recurrent, and light-chain amyloidosis.

Neurology and Neuromuscular Disorders

Clinical studies address multiple sclerosis, relapsing multiple sclerosis, progressive multiple sclerosis, amyotrophic lateral sclerosis, and chronic inflammatory demyelinating polyneuropathy.

  • Multiple sclerosis
  • Amyotrophic lateral sclerosis
  • Chronic inflammatory demyelinating polyneuropathy
  • Polyneuropathy
  • Neurological disorders

Research also includes inflammatory demyelinating polyradiculoneuropathy and broader nervous system diseases.

Metabolic, Genetic, and Rare Diseases

Work in this area includes type 1 diabetes mellitus, Fabry disease, Gaucher’s disease type III, glycogen storage disease type II, and achondroplasia.

  • Type 1 diabetes mellitus
  • Fabry disease
  • Gaucher’s disease type III
  • Achondroplasia
  • Congenital, hereditary and neonatal diseases

Additional interest is shown in hemophilia, transplant rejection, Usher’s syndrome, and other nutritional and metabolic diseases.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Itepekimab on Airway Inflammation in Former Smokers with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Denmark Germany The Netherlands
  • Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark France Germany Greece Italy +3
  • Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Czechia France Germany Italy Spain
  • Study on Riliprubart for Preventing and Treating Antibody-Mediated Rejection in Adult Kidney Transplant Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain Sweden
  • Study of venglustat tablets to reduce neuropathic and abdominal pain in patients aged 16 and older with Fabry disease who are untreated or haven’t received treatment for 6 months

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Denmark Finland France Germany Greece +4
  • Study on the Effects of Riliprubart for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France Germany Italy The Netherlands Poland Spain